University of Côte d'Azur / Université Côte d'Azur

Risk-adapted modulation through deintensification of cancer treatments: an ESMO classification (2022) Hannoun-Levi JM, Gutierrez C, Polgar C, Strnad V Journal article Engineering of spontaneous emission in free space via conditional measurements (2022) Bojer M, Götzendörfer L, Bachelard R, von Zanthier J Journal article Cardiac segmentation on late gadolinium enhancement MRI: A benchmark study from multi-sequence cardiac MR segmentation challenge (2022) Zhuang X, Xu J, Luo X, Chen C, Ouyang C, Rueckert D, Campello VM, et al. Journal article The discovAIR project: a roadmap towards the Human Lung Cell Atlas (2022) Luecken MD, Zaragosi LE, Madissoon E, Sikkema L, Firsova AB, De Domenico E, Kuemmerle L, et al. Journal article In Regard to Rahimi et al. (2022) Hannoun-Levi JM, Guinot JL, Gutierrez C, Polgar C, Strnad V Journal article Allogeneic hematopoietic stem cell transplantation for adult HLH: a retrospective study by the chronic malignancies and inborn errors working parties of EBMT (2022) Machowicz R, Suarez F, Wiktor-Jedrzejczak W, Eikema DJ, De Wreede LC, Blok HJ, Isaksson C, et al. Journal article Correlation networks of spinal motor neurons that innervate lower limb muscles during a multi-joint isometric task (2022) Hug F, Avrillon S, Sarcher A, Del Vecchio A, Farina D Journal article Letter comments on: The impact of isolated local recurrence on long-term outcome in early-breast cancer patients after breast-conserving therapy (2021) Hannoun-Levi JM, Gutierrez C, Polgar C, Strnad V Journal article In regard to Van den Bruele AB et al. Management of ipsilateral breast tumor recurrence following breast conservation surgery: a comparative study of re-conservation vs mastectomy. Breast Cancer Res Treat. 2021 May;187(1):105-112. doi:10.1007/s10549-020-06080-9. Epub 2021 Jan 12. PMID: 33433775; PMCID: PMC8068641 (2021) Hannoun-Levi JM, Polgar C, Strnad V Journal article, Letter Endocrine therapy with accelerated Partial breast irradiatiOn or exclusive ultra-accelerated Partial breast irradiation for women aged >= 60 years with Early-stage breast cancer (EPOPE): The rationale for a GEC-ESTRO randomized phase III-controlled trial (2021) Hannoun-Levi JM, Chamorey E, Boulahssass R, Polgar C, Strnad V Journal article